These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 22849945)
1. [Adherence to HAART, quality of life and psychopathological symptoms among HIV/AIDS infected patients]. Margalho R; Pereira M; Ouakinin S; Canavarro MC Acta Med Port; 2011 Dec; 24 Suppl 2():539-48. PubMed ID: 22849945 [TBL] [Abstract][Full Text] [Related]
2. Gender and age differences in quality of life and the impact of psychopathological symptoms among HIV-infected patients. Pereira M; Canavarro MC AIDS Behav; 2011 Nov; 15(8):1857-69. PubMed ID: 21431413 [TBL] [Abstract][Full Text] [Related]
3. Quality of life and adherence to antiretroviral therapy in Southern Brazil. Zubaran C; Medeiros G; Foresti K; May W; Michelim L; Madi JM; AIDS Care; 2014; 26(5):619-25. PubMed ID: 24093756 [TBL] [Abstract][Full Text] [Related]
4. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy. Bouhnik AD; Préau M; Vincent E; Carrieri MP; Gallais H; Lepeu G; Gastaut JA; Moatti JP; Spire B; Antivir Ther; 2005; 10(1):53-61. PubMed ID: 15751763 [TBL] [Abstract][Full Text] [Related]
5. The effect of depressive symptoms and CD4 count on adherence to highly active antiretroviral therapy in sub-Saharan Africa. Memiah P; Shumba C; Etienne-Mesubi M; Agbor S; Hossain MB; Komba P; Niyang M; Biadgilign S J Int Assoc Provid AIDS Care; 2014; 13(4):346-52. PubMed ID: 24114726 [TBL] [Abstract][Full Text] [Related]
6. The role of anger in adherence to highly active antiretroviral treatment in patients infected with HIV. Leombruni P; Fassino S; Lavagnino L; Orofino G; Morosini P; Picardi A Psychother Psychosom; 2009; 78(4):254-7. PubMed ID: 19468260 [TBL] [Abstract][Full Text] [Related]
7. Rate and predictors of self-chosen drug discontinuations in highly active antiretroviral therapy-treated HIV-positive individuals. Murri R; Guaraldi G; Lupoli P; Crisafulli R; Marcotullio S; von Schloesser F; Wu AW AIDS Patient Care STDS; 2009 Jan; 23(1):35-9. PubMed ID: 19183079 [TBL] [Abstract][Full Text] [Related]
8. Impact of a psychoeducative intervention on adherence to HAART among low-literacy patients in a resource-limited setting: the case of an Arab country--Morocco. Khachani I; Harmouche H; Ammouri W; Rhoufrani F; Zerouali L; Abouqal R; Tazi-Mezalek Z; Adnaoui M; Aouni M; Maouni A J Int Assoc Physicians AIDS Care (Chic); 2012; 11(1):47-56. PubMed ID: 21502438 [TBL] [Abstract][Full Text] [Related]
9. Intention to adhere to HIV treatment: a patient-centred predictor of antiretroviral adherence. Nelsen A; Gupta S; Trautner BW; Petersen NJ; Garza A; Giordano TP; Naik AD; Rodriguez-Barradas MC HIV Med; 2013 Sep; 14(8):472-80. PubMed ID: 23551395 [TBL] [Abstract][Full Text] [Related]
10. Gender and other psychosocial factors as predictors of adherence to highly active antiretroviral therapy (HAART) in adults with comorbid HIV/AIDS, psychiatric and substance-related disorder. Applebaum AJ; Richardson MA; Brady SM; Brief DJ; Keane TM AIDS Behav; 2009 Feb; 13(1):60-5. PubMed ID: 18690532 [TBL] [Abstract][Full Text] [Related]
11. Self-efficacy, medication adherence, and quality of life among people living with HIV in Hunan Province of China: a questionnaire survey. Huang L; Li L; Zhang Y; Li H; Li X; Wang H J Assoc Nurses AIDS Care; 2013; 24(2):145-53. PubMed ID: 22770801 [TBL] [Abstract][Full Text] [Related]
12. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes. Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408 [TBL] [Abstract][Full Text] [Related]
13. Factors associated with adherence to highly active antiretroviral therapy among children in two referral hospitals, northwest Ethiopia. Azmeraw D; Wasie B Ethiop Med J; 2012 Apr; 50(2):115-24. PubMed ID: 22924280 [TBL] [Abstract][Full Text] [Related]
14. Medication adherence in HIV-infected smokers: the mediating role of depressive symptoms. Webb MS; Vanable PA; Carey MP; Blair DC AIDS Educ Prev; 2009 Jun; 21(3 Suppl):94-105. PubMed ID: 19537957 [TBL] [Abstract][Full Text] [Related]
15. An exploration of factors influencing adherence to highly active anti-retroviral therapy (HAART) among people living with HIV/AIDS in Northern Thailand. Ruanjahn G; Roberts D; Monterosso L AIDS Care; 2010 Dec; 22(12):1555-61. PubMed ID: 20582752 [TBL] [Abstract][Full Text] [Related]
16. Time perspective and quality of life among HIV-infected patients in the context of HAART. Préau M; Apostolidis T; Francois C; Raffi F; Spire B AIDS Care; 2007 Apr; 19(4):449-58. PubMed ID: 17453582 [TBL] [Abstract][Full Text] [Related]
17. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
18. An adherence typology: coping, quality of life, and physical symptoms of people living with HIV/AIDS and their adherence to antiretroviral treatment. Bader A; Kremer H; Erlich-Trungenberger I; Rojas R; Lohmann M; Deobald O; Lochmann R; Altmeyer P; Brockmeyer N Med Sci Monit; 2006 Dec; 12(12):CR493-500. PubMed ID: 17136004 [TBL] [Abstract][Full Text] [Related]
19. Protease inhibitor combination therapy, severity of illness, and quality of life among children with perinatally acquired HIV-1 infection. Storm DS; Boland MG; Gortmaker SL; He Y; Skurnick J; Howland L; Oleske JM; Pediatrics; 2005 Feb; 115(2):e173-82. PubMed ID: 15629958 [TBL] [Abstract][Full Text] [Related]
20. Evaluating health-related wellbeing outcomes among outpatient adults with human immunodeficiency virus infection in the HAART era. Saunders DS; Burgoyne RW Int J STD AIDS; 2002 Oct; 13(10):683-90. PubMed ID: 12396538 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]